Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sacubitril-valsartan in Heart Failure
NCT07341893Completed
- Sponsor
- Damanhour University
- Start
- Aug 2025
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of sacubitril + valsartan in heart failure (HF) (2 arms), sponsored by Damanhour University. Primary endpoints: Major Adverse Cardiovascular Events at 3 months and Left Ventricular Ejection Fraction at 3 months. Started Aug 2025; status: completed.
02
Drugs
sacubitril + valsartan
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT07341893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07341893.